Turning Point Therapeutics Inc (TPTX)

$76.01 0. (0.00%)
16:00 EDT TPTX Stock Quote Delayed 30 Minutes

TPTX Stock Soars 115% as Bristol-Myers Announces Takeover of Turning Point Therapeutics

Turning Point Therapeutics (TPTX) stock is rocketing higher on Friday following news of a deal with Bristol-Myers Squibb (BMY).

The Top Performing Sector in 2020 Will Be …

Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 3.81B
PE Ratio -11.00
EPS -6.91
Volume (Avg. Vol.)
Day's Range -
52-Week Range $23.77 - $75.78
Dividend & Yield N/A (N/A)